Free Trial

Kirin (KNBWY) Expected to Announce Earnings on Tuesday

Kirin logo with Consumer Staples background

Key Points

  • Kirin is expected to release its quarterly earnings on August 5th, forecasting earnings of $0.28 per share and revenue of $608.48 billion.
  • In the previous quarter, Kirin reported earnings of $0.20 per share, missing estimates, and revenue of $3.58 billion, below analyst expectations.
  • As of Tuesday, shares of Kirin opened at $13.44, down by 1.0%, with a market capitalization of $10.88 billion.
  • Want stock alerts on Kirin? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Kirin (OTCMKTS:KNBWY - Get Free Report) will likely be releasing its earnings data before the market opens on Tuesday, August 5th. Analysts expect Kirin to post earnings of $0.28 per share and revenue of $608.48 billion for the quarter.

Kirin (OTCMKTS:KNBWY - Get Free Report) last announced its quarterly earnings data on Tuesday, May 13th. The company reported $0.20 EPS for the quarter, missing analysts' consensus estimates of $0.21 by ($0.01). Kirin had a return on equity of 3.75% and a net margin of 2.37%. The firm had revenue of $3.58 billion during the quarter, compared to the consensus estimate of $3.74 billion.

Kirin Stock Performance

Shares of KNBWY stock traded up $0.17 during mid-day trading on Friday, reaching $13.42. The stock had a trading volume of 106,524 shares, compared to its average volume of 71,172. The firm's 50 day simple moving average is $13.98 and its 200 day simple moving average is $13.89. The company has a quick ratio of 0.72, a current ratio of 1.15 and a debt-to-equity ratio of 0.54. Kirin has a one year low of $12.25 and a one year high of $16.25. The firm has a market cap of $10.87 billion, a PE ratio of 29.16 and a beta of 0.10.

About Kirin

(Get Free Report)

Kirin Holdings Company, Limited engages in food and beverages, pharmaceuticals, and health science businesses. The company's products include beer, wine, whiskey, spirits, soft drinks, dairy products, and other products. It also produces and sells pharmaceutical products, biochemical products, and other products.

Featured Articles

Earnings History for Kirin (OTCMKTS:KNBWY)

Should You Invest $1,000 in Kirin Right Now?

Before you consider Kirin, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kirin wasn't on the list.

While Kirin currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Market’s Next Big Winners? Start Here
5 High Short Interest Stocks to Buy Before November
HUGE Upside Ahead: The Fastest Growing ETFs in the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines